Cancer News and Research

Latest Cancer News and Research

University Hospitals introduces surgical procedure for management of glaucoma in NE Ohio

With the arrival of a leading expert in glaucoma, Douglas Rhee, MD, as its chairman of the Department of Ophthalmology and Visual Sciences, University Hospitals Case Medical Center is introducing a surgical procedure for the management of glaucoma that is new to Northeast Ohio.

19 Jun 2014

59% of people believe that Alzheimer's is a typical part of aging

Alzheimer's is a fatal, progressive disease impacting at least 44 million people worldwide yet it is widely misunderstood. According to an Alzheimer's Association® 12-country survey, 59 percent of people surveyed incorrectly believe that Alzheimer's disease is a typical part of aging and 40 percent of people believe that Alzheimer's is not fatal.

19 Jun 2014

Viewpoints: Working for benefits; fears for a pill to prevent HIV; possible Medicaid strategy for Virginia

[Economist Robert] Moffitt noted in an email that "the work incentives in the government safety net have greatly increased over the last 20 years: less welfare payments if you don't work, and much greater government payments if you do."

19 Jun 2014

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Alexian Brothers Health System is suspending its effort to launch a new Medicaid program, blaming the difficulty of connecting physicians using different electronic records systems. The Arlington Heights, Ill.-based health system was spearheading a so-called accountable care entity (ACE) to coordinate the care of about 46,000 patients on Medicaid, the state-federal health insurance program for the poor and disabled. The ACEs are a form of managed care, one of Gov. Pat Quinn's initiatives to focus on preventative treatment to keep patients healthy and reduce health care costs (Schorsch, 6/17).

19 Jun 2014

Takeda decides to terminate development of orteronel for prostate cancer

Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).

19 Jun 2014

BIND Therapeutics inks research agreement with Roche to discover novel nanomedicines

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, today announced that it has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology.

19 Jun 2014

African American women with invasive breast cancer less likely to receive invasive technique

African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.

19 Jun 2014

Medicare faces cost tension with lawmakers, advocates

More than 130 lawmakers are urging the Obama administration to expand coverage for a lung-cancer test under Medicare that could cost the program billons, calling the screening important for vulnerable seniors. In a letter to the Centers for Medicare and Medicaid Services, the lawmakers called for a timely decision on coverage for low-dose CT scans for older patients at higher risk of developing lung cancer. ... A CMS spokesman said the agency's decision will be based on whether the test is "reasonable and necessary," without regard to its cost to Medicare (Yen, 6/17).

19 Jun 2014

NCCN Reimbursement Resource App now available for patients and caregivers

The National Comprehensive Cancer Network announces the availability of the NCCN Reimbursement Resource App, a free resource through which patients with cancer, providers, case managers, and payers can search for available reimbursement resources and patient assistance programs for multiple cancer types and supportive care indications.

19 Jun 2014

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

UC Irvine Health will use a $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to examine the "Transition of Care in Chronic Kidney Disease (CKD)."

19 Jun 2014

Novel way improves liposuction procedure using gold nanoparticles

Although liposuction is one of the most common and well-established cosmetic surgery procedures in the U.S., it still has its drawbacks.

19 Jun 2014

Researchers develop device that spots lung cancer

Lung cancer causes more deaths in the U.S. than the next three most common cancers combined (colon, breast, and pancreatic).

19 Jun 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections.

18 Jun 2014

La Jolla Institute researchers advance work toward vaccine for heart disease

Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.

18 Jun 2014

Tumor necrosis factor alpha antagonists not linked with increased risk of cancer

In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA.

18 Jun 2014

Research demonstrates association between diversity of gut bacteria and survival

New research, published online today in Blood, the Journal of the American Society of Hematology, suggests that the diversity of bacteria in the gastrointestinal tract of patients receiving stem cell transplants may be an important predictor of their post-transplant survival.

18 Jun 2014

New vaccine reprograms pancreatic tumors and makes them vulnerable to immunotherapy

Researchers at the Johns Hopkins Kimmel Cancer Center have developed and tested a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, essentially reprogramming these intractable cancers and potentially making them vulnerable to immune-based therapies.

18 Jun 2014

New strategy for treating neuroblastoma using modified version of heparin

Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming.

18 Jun 2014

Novogen, CanTx believe Intra-Peritoneal Trx-1 could be utilized as first-line therapy for ovarian cancer

Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.

18 Jun 2014

New breakthrough in pediatric leukaemia treatment

Melbourne researchers have shown a type of leukaemia can be successfully 'reversed' by coaxing the cancer cells back into normal development.

18 Jun 2014

Cancer News and Research

Latest Cancer News and Research

University Hospitals introduces surgical procedure for management of glaucoma in NE Ohio

59% of people believe that Alzheimer's is a typical part of aging

Viewpoints: Working for benefits; fears for a pill to prevent HIV; possible Medicaid strategy for Virginia

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Takeda decides to terminate development of orteronel for prostate cancer

BIND Therapeutics inks research agreement with Roche to discover novel nanomedicines

African American women with invasive breast cancer less likely to receive invasive technique

Medicare faces cost tension with lawmakers, advocates

NCCN Reimbursement Resource App now available for patients and caregivers

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

Novel way improves liposuction procedure using gold nanoparticles

Researchers develop device that spots lung cancer

First Edition: June 18, 2014

La Jolla Institute researchers advance work toward vaccine for heart disease

Tumor necrosis factor alpha antagonists not linked with increased risk of cancer

Research demonstrates association between diversity of gut bacteria and survival

New vaccine reprograms pancreatic tumors and makes them vulnerable to immunotherapy

New strategy for treating neuroblastoma using modified version of heparin

Novogen, CanTx believe Intra-Peritoneal Trx-1 could be utilized as first-line therapy for ovarian cancer

New breakthrough in pediatric leukaemia treatment

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in